Quadrant Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Quadrant Capital Management's NVS Position: Q4 2019 in Review
Quadrant Capital Management increased its Novartis (NVS) stake by 2.7% in Q4 2019, buying an estimated $75.8K and bringing the position to 32,216 shares worth $3.05M. The position accounts for 1.38% of the portfolio, ranked #29.
Quadrant Capital Management first reported a position in NVS in Q2 2014 and has held it in 23 quarters since. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.
- Quadrant Capital Management held 32,216 shares of Novartis worth $3.05M as of Q4 2019.
- Quadrant Capital Management bought 845 Novartis shares in Q4 2019, an estimated $75.8K.
- Novartis made up 1.38% of Quadrant Capital Management's portfolio in Q4 2019, its #29 holding.
- Quadrant Capital Management first reported a position in Novartis in Q2 2014 and has held it in 23 quarters since.
- 1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.
Based on Quadrant Capital Management's 13F filing for Q4 2019, filed 29 Jan 2020.